Doing Business At the intersection of science, law, and policy

Your global business partners for addressing legal, scientific, and regulatory challenges.

Competitive Advantage

Bergeson & Campbell, P.C. (B&C®), a Washington D.C. law firm focusing on conventional, biobased, and nanoscale industrial, agricultural, and specialty chemical product approval and regulation, product defense, and associated business issues. 

We help companies that make and use chemicals commercialize their products, maintain compliance, and gain competitive advantage as they market their products throughout the world. Our Mission is to get them to market faster and more efficiently than the competition.

More About Us
Lab and planting seeds

Knowledge & Insights

  January 6, 2025
Memoranda
2025 Forecast for U.S. Federal and International Chemical Regulatory Policy

Bergeson & Campbell, P.C. (B&C®), its global consulting affiliate The Acta Group (Acta®), and consortia management affiliate B&C®...

  December 17, 2024
Memoranda
PFAS – What to Know Now, and What to Expect

Perfluoroalkyl and polyfluoroalkyl substances (PFAS) are attracting global legal, regulatory, commercial, and litigation attention as no other...

  February 3, 2025
News & Events
B&C Seeks Professionals with TSCA, FIFRA, and FFDCA Regulatory Experience

Bergeson & Campbell, P.C. (B&C®) and The Acta Group (Acta®) are hiring. If you are a scientist or regulatory professional with 7-10 years of...

  January 28, 2025
Memoranda
EPA Releases Draft Scope Document for Vinyl Chloride TSCA Risk Evaluation

On January 16, 2025, the U.S. Environmental Protection Agency (EPA) announced the availability of and requested public comment on the draft scope of...

  January 27, 2025
Memoranda
EPA Proposes Risk Management Rule to Protect Workers from Inhalation Exposure to PV29

On January 14, 2025, the U.S. Environmental Protection Agency (EPA) issued a proposed rule to address the unreasonable risk of injury to human health...

  January 17, 2025
Memoranda
EPA Releases Final Risk Evaluation for DINP, Finding Unreasonable Risk of Injury to Human Health When Workers Are Exposed under Four COUs

On January 14, 2025, the U.S. Environmental Protection Agency (EPA) released the final risk evaluation for diisononyl phthalate (DINP) conducted under...

  January 15, 2025
Monthly Federal Developments Memorandum
Recent Federal Developments for January 2025

2025 Forecast For U.S. Federal And International Chemical Regulatory Policy: On January 6, 2025, Bergeson & Campbell, P.C. (B&C®), The Acta...

  January 15, 2025
Memoranda
EPA and OSHA Sign MOU for Implementation of TSCA Section 6

The U.S. Environmental Protection Agency (EPA) announced on January 13, 2025, that it signed a long-awaited memorandum of understanding (MOU) with the...

Seminars & Webinars

  December 10, 2024
Seminars & Webinars
What’s New with New Approach Methodologies: A Webinar, February 13, 2025 11:00 a.m. – 12:30 p.m. (EST), via webinar

Bergeson & Campbell, P.C. (B&C®) is pleased to present “What’s New with New Approach Methodologies: A Webinar.” New Approach...

  December 10, 2024
Seminars & Webinars
Environmental Law 2025: Tackling the Issues in a Pivotal Year, February 20 – 21, 2025, Washington, D.C. and via webcast

ALI CLE presents “Environmental Law 2025: Tackling the Issues in a Pivotal Year,” a two-day program on what lies ahead in a pivotal year...

  December 20, 2024
Seminars & Webinars
TSCA Developments 2025, February 27, 2025, via webinar

Chemical Watch presents TSCA Developments 2025, covering TSCA and its business-critical implications, including TSCA inventory updates, risk...

We partner with our clients to help them get products quickly and efficiently to market–in any country or locale–and keep them there.

Our Firms
Map of Bergeson & Campbell locations

our people

Government affairs experts, including six high-level EPA alumni. Experienced industry and agency scientists, including organic chemists, toxicologists, exposure experts, five Ph.D.'s. Trusted, respected, and highly rated attorneys who have worked on some of the toughest regulatory and legal issues of our time.

B&C, Acta, and BCCM provide a full range of global support for the commercialisation of chemicals, biocides, and products of industrial biotechnology, nanotechnology, and synthetic biology.

Hexagons image collage

A true business partner with clients, B&C delivers vital expertise in business strategy development, compliance planning, product defense, policy advocacy, and related activities.